Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 2021
Historique:
received: 07 09 2020
revised: 22 10 2020
accepted: 23 10 2020
pubmed: 3 11 2020
medline: 25 9 2021
entrez: 2 11 2020
Statut: ppublish

Résumé

Trace amine-associated receptors (TAARs) are a class of sensory G protein-coupled receptors that detect biogenic amines, products of decarboxylation of amino acids. The majority of TAARs (TAAR2-TAAR9) have been described mainly in the olfactory epithelium and considered to be olfactory receptors sensing innate odors. However, there is recent evidence that one of the members of this family, TAAR5, is expressed also in the limbic brain areas receiving projection from the olfactory system and involved in the regulation of emotions. In this study, we further characterized a mouse line lacking TAAR5 (TAAR5 knockout, TAAR5-KO mice) that express beta-galactosidase mapping TAAR5 expression. We found that in TAAR5-KO mice the number of dopamine neurons, the striatal levels of dopamine and its metabolites, as well as striatal levels of GDNF mRNA, are elevated indicating a potential increase in dopamine neuron proliferation. Furthermore, an analysis of TAAR5 beta-galactosidase expression revealed that TAAR5 is present in the major neurogenic areas of the brain such as the subventricular zone (SVZ), the subgranular zone (SGZ) and the less characterized potentially neurogenic zone surrounding the 3rd ventricle. Direct analysis of neurogenesis by using specific markers doublecortin (DCX) and proliferating cell nuclear antigen (PCNA) revealed at least 2-fold increase in the number of proliferating neurons in the SVZ and SGZ of TAAR5-KO mice, but no such markers were detected in mutant or control mice in the areas surrounding the 3rd ventricle. These observations indicate that TAAR5 involved not only in regulation of emotional status but also adult neurogenesis and dopamine transmission. Thus, future TAAR5 antagonists may exert not only antidepressant and/or anxiolytic action but may also provide new treatment opportunity for neurodegenerative disorders such as Parkinson's disease.

Identifiants

pubmed: 33132188
pii: S0028-3908(20)30441-X
doi: 10.1016/j.neuropharm.2020.108373
pii:
doi:

Substances chimiques

Dcx protein, mouse 0
Doublecortin Protein 0
Receptors, G-Protein-Coupled 0
trace amine-associated receptor 5, mouse 0
Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108373

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Evgeniya V Efimova (EV)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia.

Alena A Kozlova (AA)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia.

Valeria Razenkova (V)

Institute of Experimental Medicine, St. Petersburg, 197376 Russia.

Nataliia V Katolikova (NV)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia.

Kristina A Antonova (KA)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia.

Tatyana D Sotnikova (TD)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia.

Natalia S Merkulyeva (NS)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia; Pavlov Institute of Physiology RAS, St. Petersburg, Russia.

Aleksandr S Veshchitskii (AS)

Pavlov Institute of Physiology RAS, St. Petersburg, Russia.

Daria S Kalinina (DS)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia.

Dmitry E Korzhevskii (DE)

Institute of Experimental Medicine, St. Petersburg, 197376 Russia.

Pavel E Musienko (PE)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia; St. Petersburg State Research Institute of Phthisiopulmonology, Ministry of Healthcare of the RF, St. Petersburg, 191036, Russia.

Evgeny V Kanov (EV)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia.

Raul R Gainetdinov (RR)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia; St. Petersburg University Hospital, St. Petersburg State University, St. Petersburg, 199034, Russia. Electronic address: gainetdinov.raul@gmail.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH